Investitionsthese
Arkin Capital is a multi-asset manager investing across health, technology, equity, and real estate, focusing on strategic opportunities in biotech, digital health, early-stage tech, and global real estate markets.
Investitionsphase
Early-stage to late-stage (biotech, digital health), seed to Series B (tech), and active/realized (real estate)
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Health technologies, biotech, digital health, early-stage tech, real estate (residential, commercial, industrial), and equity investments
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
k.A.
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...
Investment Team (32)

ADAR MAKOVSKI SILVERSTEIN
Principal

ALON LAZARUS
Managing Partner
A
Adar Makovski Silverstein
Principal
A
Alon Lazarus
Managing Partner

Avital Adlar
Principal

CHEN KOTON
Direct Equity
C
Chen Koton
Direct Equity
DAVID ALTERMAN
Principal
D
David Alterman
Principal
E
Eyal Bakshei
Investment Professional
E
Eyal Bakshi
Investment Professional
GUY TOBER
Principal
G
Guy Tober
Principal
I
Itai Arkin
Director, Global Capital Markets
MAXIM KATSENELSON
Investment Analyst
M
Maxim Katsenelson
Investment Analyst
M
Mori Arkin
Founder & Chairman
N
NADAV SHIMONI
Managing Partner
N
NIMROD BAR
Managing Director
N
Nadav Shimoni
Managing Partner
N
Nimrod Bar
Managing Director
N
Nir Arkin
CEO
O
ORI AMSALEM
Principal
O
Ori Amsalem
Principal

PINI ORBACH
Managing Partner
P
Pini Orbach
Managing Partner
R
Rivka Uliel
Tax Director
S
SAM CRONIN
Partner
S
Sam Cronin
Partner
T
Tomer Katz
Investment Professional
Y
Yair Ben Yosef
Director of Finance

Yaniv Cohen
Managing Director